Evidence map›Paper›PMID 38882037›Full record

ReviewACS polymers Au2024

Silk Fibroin and Its Nanocomposites for Wound Care: A Comprehensive Review.

Sushma Indrakumar, Tapan Kumar Dash, Vivek Mishra, Bharat Tandon, Kaushik Chatterjee

Abstract readReview
In one paragraph

Review in ACS polymers Au, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Inhibition ofPolymers · 2025
    Article
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sushma IndrakumarDepartment of Materials Engineering, Indian Institute of Science, Bangalore 560012, India.
Tapan Kumar DashFibroheal Woundcare Pvt. Ltd., Yelahanka New Town, Bangalore 560064, India.ORCID https://orcid.org/0000-0003-1954-3032
Vivek MishraFibroheal Woundcare Pvt. Ltd., Yelahanka New Town, Bangalore 560064, India.
Bharat TandonFibroheal Woundcare Pvt. Ltd., Yelahanka New Town, Bangalore 560064, India.
Kaushik ChatterjeeDepartment of Materials Engineering, Indian Institute of Science, Bangalore 560012, India.ORCID https://orcid.org/0000-0002-7204-2926

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For most individuals, wound healing is a highly organized, straightforward process, wherein the body transitions through different phases in a timely manner. However, there are instances where external intervention becomes necessary to support and facilitate different phases of the body's innate healing mechanism. Furthermore, in developing countries, the cost of the intervention significantly impacts access to treatment options as affordability becomes a determining factor. This is particularly true in cases of long-term wound treatment and management, such as chronic wounds and infections. Silk fibroin (SF) and its nanocomposites have emerged as promising biomaterials with potent wound-healing activity. Driven by this motivation, this Review presents a critical overview of the recent advancements in different aspects of wound care using SF and SF-based nanocomposites. In this context, we explore various formats of hemostats and assess their suitability for different bleeding situations. The subsequent sections discuss the primary causes of nonhealing wounds, i.e., prolonged inflammation and infections. Herein, different treatment strategies to achieve immunomodulatory and antibacterial properties in a wound dressing were reviewed. Despite exhibiting excellent pro-healing properties, few silk-based products reach the market. This Review concludes by highlighting the bottlenecks in translating silk-based products into the market and the prospects for the future.

Identifiers

PMID38882037
PMCPMC11177305

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.